FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024883410> ?p ?o ?g. }

• W2024883410 endingPage "1575" @default.
• W2024883410 startingPage "1565" @default.
• W2024883410 abstract "In Brief Study Design. A prospective, randomized, multicenter, Food and Drug Administration-regulated Investigational Device Exemption clinical trial. Objectives. The purpose of this study was to compare the safety and effectiveness of lumbar total disc replacement, using the CHARITÉ™ artificial disc (DePuy Spine, Raynham, MA), with anterior lumbar interbody fusion, for the treatment of single-level degenerative disc disease from L4-S1 unresponsive to nonoperative treatment. Summary of Background Data. Reported results of lumbar total disc replacement have been favorable, but studies have been limited to retrospective case series and/or small sample sizes. Methods. Three hundred four (304) patients were enrolled in the study at 14 centers across the United States and randomized in a 2:1 ratio to treatment with the CHARITÉ™ artificial disc or the control group, instrumented anterior lumbar interbody fusion. Data were collected pre- and perioperatively at 6 weeks and at 3, 6, 12, and 24 months following surgery. The key clinical outcome measures were a Visual Analog Scale assessing back pain, the Oswestry Disability Index questionnaire, and the SF-36 Health Survey. Results. Patients in both groups improved significantly following surgery. Patients in the CHARITÉ™ artificial disc group recovered faster than patients in the control group. Patients in the CHARITÉ™ artificial discgroup had lower levels of disability at every time interval from 6 weeks to 24 months, compared with the control group, with statistically lower pain and disability scores at all but the 24 month follow-up (P < 0.05). At the 24-month follow-up period, a significantly greater percentage of patients in the CHARITÉ™ artificial disc group expressed satisfaction with their treatment and would have the same treatment again, compared with the fusion group (P < 0.05). The hospital stay was significantly shorter in the CHARITÉ™ artificial disc group (P < 0.05). The complication rate was similar between both groups. Conclusions. This prospective, randomized, multicenter study demonstrated that quantitative clinical outcome measures following lumbar total disc replacement with the CHARITÉ™ artificial disc are at least equivalent to clinical outcomes with anterior lumbar interbody fusion. These results support earlier reports in the literature that total disc replacement with the CHARITÉ™ artificial disc is a safe and effective alternative to fusion for the surgical treatment of symptomatic disc degeneration in properly indicated patients. The CHARITÉ™ artificial disc group demonstrated statistically significant superiority in two major economic areas, a 1-day shorter hospitalization, and a lower rate of reoperations (5.4% compared with 9.1%). At 24 months, the investigational group had a significantly higher rate of satisfaction (73.7%) than the 53.1% rate of satisfaction in the control group (P = 0.0011). This prospective randomized multicenter study also demonstrated an increase in employment of 9.1% in the investigational group and 7.2% in the control group. A prospective, randomized, multicenter study was performed to compare the safety and effectiveness of lumbar total disc replacement with the Charité™ artificial disc to anterior lumbar interbody fusion. Clinical outcomes in the disc replacement group were similar to clinical outcomes in the control group. Lumbar total disc replacement with the Charité™ artificial disc is a safe and effective alternative to fusion for symptomatic disc degeneration at one-level from L4-S1 in properly indicated patients." @default.
• W2024883410 created "2016-06-24" @default.
• W2024883410 creator A5020621240 @default.
• W2024883410 creator A5023248680 @default.
• W2024883410 creator A5052367382 @default.
• W2024883410 creator A5064387836 @default.
• W2024883410 creator A5066675060 @default.
• W2024883410 creator A5068613903 @default.
• W2024883410 creator A5069184743 @default.
• W2024883410 creator A5072765020 @default.
• W2024883410 creator A5089213829 @default.
• W2024883410 date "2005-07-01" @default.
• W2024883410 modified "2023-10-16" @default.
• W2024883410 title "A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemptions Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artificial Disc Versus Lumbar Fusion" @default.
• W2024883410 cites W1581707964 @default.
• W2024883410 cites W2010117675 @default.
• W2024883410 cites W2043866581 @default.
• W2024883410 cites W2068353469 @default.
• W2024883410 cites W2070509536 @default.
• W2024883410 cites W2071763312 @default.
• W2024883410 cites W2127338742 @default.
• W2024883410 cites W2135815967 @default.
• W2024883410 cites W2143949977 @default.
• W2024883410 cites W2147174358 @default.
• W2024883410 cites W2330108134 @default.
• W2024883410 cites W2792052114 @default.
• W2024883410 doi "https://doi.org/10.1097/01.brs.0000170587.32676.0e" @default.
• W2024883410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16025024" @default.
• W2024883410 hasPublicationYear "2005" @default.
• W2024883410 type Work @default.
• W2024883410 sameAs 2024883410 @default.
• W2024883410 citedByCount "524" @default.
• W2024883410 countsByYear W20248834102012 @default.
• W2024883410 countsByYear W20248834102013 @default.
• W2024883410 countsByYear W20248834102014 @default.
• W2024883410 countsByYear W20248834102015 @default.
• W2024883410 countsByYear W20248834102016 @default.
• W2024883410 countsByYear W20248834102017 @default.
• W2024883410 countsByYear W20248834102018 @default.
• W2024883410 countsByYear W20248834102019 @default.
• W2024883410 countsByYear W20248834102020 @default.
• W2024883410 countsByYear W20248834102021 @default.
• W2024883410 countsByYear W20248834102022 @default.
• W2024883410 countsByYear W20248834102023 @default.
• W2024883410 crossrefType "journal-article" @default.
• W2024883410 hasAuthorship W2024883410A5020621240 @default.
• W2024883410 hasAuthorship W2024883410A5023248680 @default.
• W2024883410 hasAuthorship W2024883410A5052367382 @default.
• W2024883410 hasAuthorship W2024883410A5064387836 @default.
• W2024883410 hasAuthorship W2024883410A5066675060 @default.
• W2024883410 hasAuthorship W2024883410A5068613903 @default.
• W2024883410 hasAuthorship W2024883410A5069184743 @default.
• W2024883410 hasAuthorship W2024883410A5072765020 @default.
• W2024883410 hasAuthorship W2024883410A5089213829 @default.
• W2024883410 hasConcept C126322002 @default.
• W2024883410 hasConcept C141071460 @default.
• W2024883410 hasConcept C14184104 @default.
• W2024883410 hasConcept C142724271 @default.
• W2024883410 hasConcept C168563851 @default.
• W2024883410 hasConcept C188816634 @default.
• W2024883410 hasConcept C204787440 @default.
• W2024883410 hasConcept C2775998654 @default.
• W2024883410 hasConcept C2778051963 @default.
• W2024883410 hasConcept C2778620186 @default.
• W2024883410 hasConcept C2779806092 @default.
• W2024883410 hasConcept C2779835254 @default.
• W2024883410 hasConcept C2780907711 @default.
• W2024883410 hasConcept C44249647 @default.
• W2024883410 hasConcept C44575665 @default.
• W2024883410 hasConcept C535046627 @default.
• W2024883410 hasConcept C71924100 @default.
• W2024883410 hasConceptScore W2024883410C126322002 @default.
• W2024883410 hasConceptScore W2024883410C141071460 @default.
• W2024883410 hasConceptScore W2024883410C14184104 @default.
• W2024883410 hasConceptScore W2024883410C142724271 @default.
• W2024883410 hasConceptScore W2024883410C168563851 @default.
• W2024883410 hasConceptScore W2024883410C188816634 @default.
• W2024883410 hasConceptScore W2024883410C204787440 @default.
• W2024883410 hasConceptScore W2024883410C2775998654 @default.
• W2024883410 hasConceptScore W2024883410C2778051963 @default.
• W2024883410 hasConceptScore W2024883410C2778620186 @default.
• W2024883410 hasConceptScore W2024883410C2779806092 @default.
• W2024883410 hasConceptScore W2024883410C2779835254 @default.
• W2024883410 hasConceptScore W2024883410C2780907711 @default.
• W2024883410 hasConceptScore W2024883410C44249647 @default.
• W2024883410 hasConceptScore W2024883410C44575665 @default.
• W2024883410 hasConceptScore W2024883410C535046627 @default.
• W2024883410 hasConceptScore W2024883410C71924100 @default.
• W2024883410 hasIssue "14" @default.
• W2024883410 hasLocation W20248834101 @default.
• W2024883410 hasLocation W20248834102 @default.
• W2024883410 hasOpenAccess W2024883410 @default.
• W2024883410 hasPrimaryLocation W20248834101 @default.
• W2024883410 hasRelatedWork W2024883410 @default.
• W2024883410 hasRelatedWork W2060860213 @default.
• W2024883410 hasRelatedWork W2084002837 @default.
• W2024883410 hasRelatedWork W2117544172 @default.
• W2024883410 hasRelatedWork W2147174358 @default.

• next